G
Gordon H. Guyatt
Researcher at McMaster University
Publications - 1749
Citations - 262329
Gordon H. Guyatt is an academic researcher from McMaster University. The author has contributed to research in topics: Randomized controlled trial & Medicine. The author has an hindex of 231, co-authored 1620 publications receiving 228631 citations. Previous affiliations of Gordon H. Guyatt include Memorial Sloan Kettering Cancer Center & Cayetano Heredia University.
Papers
More filters
Journal Article
Long-term outcome after respiratory rehabilitation
TL;DR: Of the 31 consecutive patients enrolled in a multidisciplinary inpatient rehabilitation program, 24 showed improvement in quality of life and in functional exercise capacity 2 weeks after discharge, and the improvement was sustained for 6 months in 11 of the 24.
Journal ArticleDOI
Profile of mood states and cardiac rehabilitation after acute myocardial infarction.
TL;DR: Overall, rehabilitation and control patients showed similar and significant improvements in anxiety, depression and in mood states over the duration of the 12-month trial.
Journal ArticleDOI
Computer searching of the medical literature. An evaluation of MEDLINE searching systems.
R. Brian Haynes,K Ann McKibbon,C J Walker,Johanna Mousseau,Lynda M. Baker,Dorothy Fitzgerald,Gordon H. Guyatt,Geoffrey R. Norman +7 more
TL;DR: Clinicians should consider major differences when deciding which search system to use, including the higher the cost, the worse the product.
letters-and-commentsDOI
Tranexamic Acid in Patients Undergoing Noncardiac Surgery.
Philip J. Devereaux,Maura Marcucci,Thomas Painter,David Cohen,Vladimir V. Lomivorotov,Daniel I. Sessler,Flávia Kessler Borges,Maria José Martinez-Zapata,Chew Yin Wang,Denis Xavier,Sandra N Ofori,Michael Ke Wang,Sergey M. Efremov,Giovanni Landoni,Ydo V. Kleinlugtenbelt,Wojciech Szczeklik,Denis Schmartz,Amit X. Garg,Timothy G. Short,Maria Wittmann,Christian S. Meyhoff,Mohammed Amir,David Torres,Ameen Patel,Emmanuelle Duceppe,Kurt Ruetzler,Joel L. Parlow,Vikas Tandon,Edith Fleischmann,Carisi Anne Polanczyk,Andre Lamy,S. V. Astrakov,Mangala Rao,William K.K. Wu,K. Bhatt,Miriam de Nadal,Valery Likhvantsev,Pilar Paniagua,Héctor J. Aguado,Richard P. Whitlock,Michael McGillion,Michael Prystajecky,Jessica Vincent,John W. Eikelboom,Ingrid Copland,Kumar Balasubramanian,Alparslan Turan,Shrikant I. Bangdiwala,David Stillo,Peter L. Gross,Teresa Cafaro,P. Alfonsi,Pavel S Roshanov,Emilie P. Belley-Côté,Jessica Spence,Toby Richards,Tomas VanHelder,William L. McIntyre,Gordon H. Guyatt,Salim Yusuf,Kate Leslie +60 more
TL;DR: Among patients undergoing noncardiac surgery, the incidence of the composite bleeding outcome was significantly lower with tranexamic acid than with placebo, and the between-group difference in the composite cardiovascular outcome was small, the noninferiority of tranxamic acid was not established.
Journal ArticleDOI
Drugs for pre-osteoporosis: prevention or disease mongering?
TL;DR: After looking at data used to support treatment of women with slightly lowered bone mineral density, Pablo Alonso-Coello and colleagues argue that proponents have overstated the benefits and underplayed the harms.